FDA NDC Directory · JSON-LD · Markdown

Oxybutynin Chloride

NDC 0904-6570 · HUMAN PRESCRIPTION DRUG · TABLET, EXTENDED RELEASE

Labeler / ManufacturerMajor Pharmaceuticals
Marketing categoryAbbreviated NDA (generic) · App ANDA204010
Dosage form / routeTABLET, EXTENDED RELEASE · ORAL
Active ingredientsOXYBUTYNIN CHLORIDE (5 mg/1)
Marketing started20151102
Package count3

External sources

Source: openFDA. Public-domain (CC0).